Announced Tue, 7 Jul · 18:45 IST
Quarterly Share Capital Audit Report filed for Q1 FY27
Compliance View source PDF
SENORES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.0%1-day move
₹1363.50
prior close
₹1360.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.1+2.1+3.3+2.5+4.0+3.7+5.2+7.1+8.5+2.8————
Up moveDown movePending
AI summary
Senores Pharmaceuticals has submitted its Reconciliation of Share Capital Audit Report for the quarter ended June 30, 2026, to BSE and NSE. This is a routine quarterly compliance filing required under Regulation 76 of the SEBI Depositories and Participants Regulations, 2018. The report, dated July 07, 2026, was signed by practicing company secretary Mr. Tapan Shah and filed by Whole Time Director and CFO Deval Rajnikant Shah.
Likely market impact
Routine regulatory compliance filing with no material impact on shareholders or the stock price.